“showed a trend”

JAK1-selective inhibitor showed a trend for better retention rate compared to pan-JAK inhibitors ( p = 0.12; Figure 3 ).

Surface SERT binding showed a trend toward a decrease in maximal binding in ‘ S ' allele carriers ( Figure 3b ; P <0.12).

Osteoid surface to bone surface showed a trend toward a reduction in CRH‐Tg mice ( p = 0.12; Fig. 3 C ), whereas osteoid width was decreased by 27% in CRH‐Tg mice relative to WT mice ( p = 0.002; Fig. 3 D ).

For protons, 200 cGy caused a −22% decrement in BV/TV ( Figure 3 A) and Tb.N ( Figure 3 B), while 50 cGy showed a trend towards decreased BV/TV (−11%, p = 0.12) and Tb.N (−13%, p = 0.06).

Analysis of dependency of BIS-reduction on daytime showed a trend for HGSHS-5 (BIS total intervention) with 88.8 at noon vs. 90.5 in the morning and evening ( p = 0.12).

Conversely, those with CTNNB1 mutations showed a trend toward longer OS (P=0.12) ( Figure 4B ).

This effect was not observed with high-dose vaccine, where Pfs25 showed a trend to lower antibody levels after coadministration of the 2 vaccines ( Figure 2G compared with Figure 2B, P = 0.12), and there was no effect of vaccine combinations on anti-Pfs230 responses ( Figure 2, H and I ).

Among DLBCL cases, non‐GCB subtypes showed a trend toward greater SPSM diversity and shorter survival ( p = 0.12), though this difference was not statistically significant.

Co‐mutated cases showed a trend towards higher proliferation index (51–75%; p = 0.12, supplementary material, Figure S5E ), and AKR1B10 expression level trended towards increased Ki67 proliferation index ( p = 0.06; supplementary material, Figure S5F ).

Only the treated male mice showed a trend ( p = 0.12) to improved performance as indicated by an increase in spontaneous alteration rate.

This study showed a trend toward an increase in cerebral palsy in those exposed to multiple courses (2.9%, n = 6 vs. 0.5%, n = 1; P = 0.12).

Among patients without CA, there were 10 (12.7%) cardiovascular deaths, 47 (59.5%) non-cardiovascular deaths, and 22 (27.8%) deaths from unknown causes. In-hospital outcomes did not differ between patients with CA at presentation or in the acute phase ( Table 2 ), though the latter showed a trend towards higher 60-day mortality (33.3% vs. 52.6%, P = 0.12).

ACL-D at 5km/h); conversely, although on average ACL-R subjects showed a trend towards hypercorrection of step length (greater reduction of step length in BW), this difference did not reach statistical significance (p=0.12 ACL-R vs.

On WATER DAY, glucose concentration did not change at any moment, except for the FG on FATIGUE, which showed a trend to a higher glucose concentration compared to rest (WATER DAY–97.2 ± 16.72 mg/dl FG REST; 118 ± 39.1 mg/dl FG FATIGUE p = 0.12) this glucose increase happened due to the high intensity of the fatigue protocol and the consequent hormonal responses to the stress stimulus, as promoted by the HPA axis activation [ 18 ].

Similarly, CST reduction showed a trend favoring the ranibizumab group (−61.3 μm [−128.7 to + 6.1] vs. + 29.4 μm [−18.2 to + 77.0], p = 0.12).

The duration of motor block showed a trend towards being shorter in the reduced-dose fractionated group (Group B: 178 ± 43 min, Group F7: 169 ± 53 min, Group F6: 155 ± 33 min, p = 0.12), though this difference did not reach statistical significance.

In the group treated with carboplatin, the results showed a trend towards worse survival in TTF-1 − patients, with an OS of 1 month (95% CI: 0–2.3) compared to 4 months (95% CI: 0–10.4) in TTF-1 + patients (P=0.12).

RFS Kaplan‐Meier curves and log‐rank testing showed a trend towards decreased ( P = .120) survival probability in high ADI in the p16‐positive population with a 5‐year RFS of 64.5% relative to 76.8% in the low ADI group, though this difference was not significant ( Figure 2 ).

The lobular carcinomas in the present series all fell into the grade 2 category and also showed a trend for increase of expression (chi-squared test P = 0.12; Table 2 ) of NR4A1 compared with grade 3 primary infiltrating ductal carcinomas.

Similarly, the average number of cells per somite showed a trend toward an increase in the experimental group compared to controls (control vs. experiment: 237 ± 107 vs. 550 ± 117, p = 0.12, Figure 6c ), indicating that NAD(H) may promote the proliferation of PSM‐like progenitor cells.

After propensity‐score adjustment, PF‐AES showed a trend toward a lower rate of MACCE and a favorable rate of TLF as compared to PP‐ZES (HR 0.70; 95%CI 0.45 to 1.10, P = 0.12; and HR 0.88; 95%CI 0.47 to 1.65, P = 0.68, respectively).

We found that SNPs rs9402373 (P = 0.005; OR = 2.6) and rs3037970 (P = 0.05; OR = 2) were associated with this phenotype; SNP rs1256196 also showed a trend for an association with this more severe disease phenotype (P = 0.12).

The strength of the AVH-related IFG activation showed a trend towards explaining better ( z = 1.2, P = 0.12) the individual SRH than did the strength of any AVH-related activation in the temporal lobe, including the auditory cortices.

Similarly, interventions using either probiotics or FMT were associated with an increased ORR (pooled OR = 1.62, P = 0.006) and showed a trend toward improved DCR (pooled OR = 1.74, P = 0.12).

The inclusion of center-based cluster effects showed a trend towards ( P =0.12) improved model fit compared with fitting the same model using ordinary logistic regression with no clustering.